The selection of background and predictor variables was guided by a widely accepted psychological/health behavior theory [13] and included an objective physician collected RA activity measure, the CDAI, plus patient reported outcomes of disability, appraisal of disease control as well as DMARD side effects, TNF knowledge, and validated screening measures for depression and HL. This evidence concerns the gene TNF and rheumatoid arthritis.